Table 1.
Food Intolerance/Malabsorption | Number (n) of Patients | Percent (%) of Patients | Number (n) of Patients with High FCAL | Percent (%) of Patients with High FCAL |
---|---|---|---|---|
Number of patients | 228 | 100 | 39 | 17.1 |
LIT-only | 49 | 21.5 | 14 | 28.6 |
FM-only | 22 | 9.6 | 3 | 13.6 |
HIT-only | 29 | 12.7 | 6 | 20.7 |
H. pylori-only | 10 | 4.4 | 0 | 0 |
LIT + FM | 18 | 7.9 | 2 | 11.1 |
LIT + FM + HIT | 21 | 9.2 | 1 | 4.8 |
LIT + HIT | 34 | 14.9 | 5 | 14.7 |
LIT + H. pylori | 14 | 6.1 | 4 | 28.6 |
LIT + HIT + H. pylori | 4 | 1.7 | 0 | 0 |
LIT + FM + H. pylori | 5 | 2.2 | 0 | 0 |
LIT + FM + HIT + H. pylori | 2 | 0.9 | 0 | 0 |
FM + HIT | 11 | 4.8 | 1 | 9.1 |
FM + HIT + H. pylori | 5 | 2.2 | 0 | 0 |
FM + H. pylori | 1 | 0.4 | 1 | 100 |
HIT + H. pylori | 2 | 0.9 | 1 | 50 |
Candesartan | 1 | 0.4 | 1 | 100 |
LIT, lactose intolerance; FCAL, calprotectin; FM, fructose malabsorption; HIT, histamine intolerance; H. pylori, Helicobacter pylori.